Concord Healthcare Group Co (HKSE:02453) EBIT: HK$-204.4 Mil (TTM As of Dec. 2025)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

HKSE:02453 Concord Healthcare Group Co Ltd HKSE:02453
30 GF Score
Price HK$0.71
! 6 Warning Signs
View Full Analysis

What is Concord Healthcare Group Co EBIT?

Concord Healthcare Group Co HKSE:02453 +1.43% 30 EBIT is HK$-204.4 Mil as of Dec. 2025. GuruFocus rates HKSE:02453 with a GF Score™ of 30/100. The stock has 6 warning signs investors should review.

Concord Healthcare Group Co's earnings before interest and taxes (EBIT) for the six months ended in Dec. 2025 was HK$-56.2 Mil. Its earnings before interest and taxes (EBIT) for the trailing twelve months (TTM) ended in Dec. 2025 was HK$-204.4 Mil.

EBIT or Operating Income is linked to Return on Capital for both regular definition and Joel Greenblatt's definition. Concord Healthcare Group Co's annualized ROC % for the quarter that ended in Dec. 2025 was -3.02%. Concord Healthcare Group Co's annualized ROC (Joel Greenblatt) % for the quarter that ended in Dec. 2025 was -2.72%.

EBIT is also linked to Joel Greenblatt's definition of earnings yield. Concord Healthcare Group Co's Earnings Yield (Joel Greenblatt) % for the quarter that ended in Dec. 2025 was -5.12%.

Concord Healthcare Group Co  (HKSE:02453) EBIT Explanation

1. EBIT or Operating Income is linked to Return on Capital for both regular definition and Joel Greenblatt's definition.

Concord Healthcare Group Co's annualized ROC % for the quarter that ended in Dec. 2025 is calculated as:

ROC % (Q: Dec. 2025 )
=NOPAT/Average Invested Capital
=Operating Income * ( 1 - Tax Rate % )/( (Invested Capital (Q: Jun. 2025 ) + Invested Capital (Q: Dec. 2025 ))/ count )
=-200.77 * ( 1 - 2.09% )/( (6428.973 + 6577.959)/ 2 )
=-196.573907/6503.466
=-3.02 %

where

Invested Capital(Q: Jun. 2025 )
=Total Assets - Accounts Payable & Accrued Expense - Excess Cash
=Total Assets - Accounts Payable & Accrued Expense - ( Cash, Cash Equivalents, Marketable Securities - max(0, Total Current Liabilities - Total Current Assets+Cash, Cash Equivalents, Marketable Securities))
=6309.361 - 459.435 - ( 185.851 - max(0, 1215.258 - 636.211+185.851))
=6428.973

Invested Capital(Q: Dec. 2025 )
=Total Assets - Accounts Payable & Accrued Expense - Excess Cash
=Total Assets - Accounts Payable & Accrued Expense - ( Cash, Cash Equivalents, Marketable Securities - max(0, Total Current Liabilities - Total Current Assets+Cash, Cash Equivalents, Marketable Securities))
=6393.494 - 451.897 - ( 325.315 - max(0, 1376.161 - 739.799+325.315))
=6577.959

Note: The Operating Income data used here is two times the semi-annual (Dec. 2025) data.

2. Joel Greenblatt's definition of Return on Capital:

Concord Healthcare Group Co's annualized ROC (Joel Greenblatt) % for the quarter that ended in Dec. 2025 is calculated as:

ROC (Joel Greenblatt) %(Q: Dec. 2025 )
=EBIT/Average of (Net fixed Assets + Net Working Capital)
=EBIT/Average of (Property, Plant and Equipment+Net Working Capital)
     Q: Jun. 2025  Q: Dec. 2025
=EBIT/( ( (Property, Plant and Equipment + Net Working Capital) + (Property, Plant and Equipment + Net Working Capital) )/ count )
=-112.302/( ( (4341.152 + max(-442.745, 0)) + (3921.371 + max(-348.909, 0)) )/ 2 )
=-112.302/( ( 4341.152 + 3921.371 )/ 2 )
=-112.302/4131.2615
=-2.72 %

where Working Capital is:

Working Capital(Q: Jun. 2025 )
=(Accounts Receivable + Total Inventories + Other Current Assets) - (Accounts Payable & Accrued Expense + Defer. Rev. + Other Current Liabilities)
=(42.798 + 14.965 + 236.116) - (459.435 + 0 + 277.189)
=-442.745

Working Capital(Q: Dec. 2025 )
=(Accounts Receivable + Total Inventories + Other Current Assets) - (Accounts Payable & Accrued Expense + Defer. Rev. + Other Current Liabilities)
=(50.604 + 18.61 + 260.226) - (451.897 + 0 + 226.452)
=-348.909

When net working capital is negative, 0 is used.

Note: The EBIT data used here is two times the semi-annual (Dec. 2025) EBIT data.

3. It is also linked to Joel Greenblatt's definition of Earnings Yield:

Concord Healthcare Group Co's Earnings Yield (Joel Greenblatt) % for today is calculated as:

Earnings Yield (Joel Greenblatt) %=EBIT (TTM)/Enterprise Value (Q: Dec. 2025 )
=-204.439/3996.230
=-5.12 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Concord Healthcare Group Co EBIT Related Terms

Concord Healthcare Group Co EBIT Historical Data

* Premium members only.

The historical data trend for Concord Healthcare Group Co's EBIT can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Concord Healthcare Group Co EBIT Chart

Concord Healthcare Group Co Annual Data
Trend Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
EBIT
Get a 7-Day Free Trial -491.04 -416.19 -355.03 -402.07 -206.02

Concord Healthcare Group Co Semi-Annual Data
Dec20 Dec21 Jun22 Dec22 Jun23 Dec23 Jun24 Dec24 Jun25 Dec25
EBIT Get a 7-Day Free Trial Premium Member Only Premium Member Only -176.16 -162.37 -241.03 -148.29 -56.15

HKSE:02453 vs HCA, THC, DVA: EBIT Comparison

For the Medical Care Facilities subindustry, Concord Healthcare Group Co's EV-to-EBIT, along with its competitors' market caps and EV-to-EBIT data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Concord Healthcare Group Co EV-to-EBIT vs Healthcare Providers & Services Industry

For the Healthcare Providers & Services industry and Healthcare sector, Concord Healthcare Group Co's EV-to-EBIT distribution charts can be found below:

* The bar in red indicates where Concord Healthcare Group Co's EV-to-EBIT falls into.


HKSE:02453
30GF Score
Concord Healthcare Group Co Ltd HKSE:02453
EBIT is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Concord Healthcare Group Co EBIT Calculation

EBIT, sometimes also called Earnings Before Interest and Taxes, is a measure of a firm's profit that includes all expenses except interest and income tax expenses. It is the difference between operating revenues and operating expenses. When a firm does not have non-operating income, then Operating Income is sometimes used as a synonym for EBIT and operating profit.

EBIT for the trailing twelve months (TTM) ended in Dec. 2025 adds up the semi-annually data reported by the company within the most recent 12 months, which was HK$-204.4 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about EBIT →
What does a EBIT of HK$-204.4 Mil mean?
Concord Healthcare Group Co (HKSE:02453) has a EBIT of HK$-204.4 Mil as of Dec. 2025. Earnings before interest and taxes is the difference between operating revenue and operating expenses. View historical data on Concord Healthcare Group Co.
Is Concord Healthcare Group Co's EBIT too high?
Concord Healthcare Group Co's current EBIT is HK$-204.4 Mil. Overall, Concord Healthcare Group Co has a GF Score™ of 30/100, reflecting its overall financial health beyond just this single metric.
How does Concord Healthcare Group Co's EBIT compare to HCA and THC?
Concord Healthcare Group Co's EBIT of HK$-204.4 Mil can be compared against companies in the Healthcare Providers & Services industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good EBIT for a Healthcare Providers & Services company?
A good EBIT depends on the Healthcare Providers & Services industry context. However, EBIT should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high EBIT mean?
A high EBIT can signal that a stock is expensive relative to its fundamentals. Earnings before interest and taxes is the difference between operating revenue and operating expenses. View historical data on Concord Healthcare Group Co. Concord Healthcare Group Co's current EBIT is HK$-204.4 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Concord Healthcare Group Co stock overvalued right now?
Concord Healthcare Group Co (HKSE:02453) has a current EBIT of HK$-204.4 Mil. The current EBIT is HK$-204.4 Mil. Concord Healthcare Group Co's overall GF Score™ is 30/100 with 6 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is EBIT calculated?
EBIT is calculated from a company's financial statements. For Concord Healthcare Group Co (HKSE:02453), the current EBIT is HK$-204.4 Mil as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Concord Healthcare Group Co Business Description

Address No. 7 Guanghua Road, Room 26A1-26A5, East Tower, Hanwei Building, Chaoyang, Beijing, CHN, 100020
Concord Healthcare Group Co Ltd is a healthcare service provider in China that specializes in oncology. The Group owns and operates four offline self-operated medical institutions and one medical institution under construction, dedicated to providing comprehensive and specialized medical services to cancer patients. It also provides medical equipment, software, and related services to third-party medical institutions. The company's revenue is generated from its hospital business and its medical equipment, software, and related services segment. Substantially all of the company's revenue is generated from the PRC.
30GF Score

Get the complete analysis for HKSE:02453

EBIT is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

HK$0.71
Price